- Home
- applications
- australia
- implants
Show results for
Refine by
Implants Product Applications In Australia
6 applications found
Postoperative bacterial endophthalmitis is a rare but devastating complication that can occur following ocular surgery.1 Without proper intervention, endophthalmitis can cause irreversible damage to structures within the retina resulting in a loss of vision.2 This inflammatory condition affecting the intraocular cavities is typically caused by a bacterial or fungal infection, with the most common causative agents including coagulase-negative staphylococci, Staphylococcus aureus, streptococci and other ...
ByPolyActiva Pty Ltd. based in Parkville, AUSTRALIA
Ocular Hypertension is defined as elevated intraocular pressure (IOP) without ocular damage and is associated with an increased risk of progression to Glaucoma.1,2 Nearly 7 million adults over the age of 40 in the US are estimated to suffer from Ocular Hypertension. ...
ByPolyActiva Pty Ltd. based in Parkville, AUSTRALIA
Premium
For the current population of adults 40 or older, the suffering from bone degeneration is approaching 90% (Nag and Banerjee, 2012), predominantly with site-specific damage such as hip and shoulder ...
ByZygo Corporation - AMETEK, Inc based in Middlefield, CONNECTICUT (USA)
Premium
Medical and life science manufacturers are pressured to drive continual innovation and advancement with short time-to-market goals. These industries also demand strict process controls and quality standards. Success often rests on the ability to choose the right partner — one that can be trusted to have the right knowledge and experience to help them meet these stringent ...
ByZygo Corporation - AMETEK, Inc based in Middlefield, CONNECTICUT (USA)
Motivate your patients to improve treatment compliance. Go beyond the scale with HF-Dex, the newest technology for point-of-care heart failure fluid ...
ByImpediMed Inc. based in Carlsbad, CALIFORNIA (USA)
GI Dynamics has taken all necessary COVID-19 precautions to ensure patient safety, which remains top priority. Patient screening for the STEP-1 pivotal trial of EndoBarrier has reopened at select sites and enrollment will be conducted according to site requirements and CDC/FDA ...
ByGI Dynamics, Inc. based in Boston, MASSACHUSETTS (USA)